AVDL - Avadel Pharmaceuticals Q2 2022 Earnings Preview
- Avadel Pharmaceuticals ( NASDAQ: AVDL ) is scheduled to announce Q2 earnings results on Monday, August 9th, before market open.
- The consensus EPS Estimate is -$0.40 (-21.2% Y/Y) and the consensus Revenue Estimate is $0M
- Over the last 3 months, EPS estimates have seen 3 upward revisions and 1 downward.
For further details see:
Avadel Pharmaceuticals Q2 2022 Earnings Preview